Prenatal Iodine Supplementation and Early Childhood Neurodevelopment (PoppiE)
Sponsor: Flinders Medical Centre
Listed as NCT04586348, this PHASE4 trial focuses on Neurodevelopmental Disorders and Nutrition Disorder, Fetal and remains ongoing. Sponsored by Flinders Medical Centre, it has been updated 7 times since 2021, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Active Not Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE4
-
May 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
May 2023 — May 2024 [monthly]
Recruiting PHASE4
-
Sep 2021 — May 2023 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
▶ Show 2 earlier versions
-
Jan 2021 — Sep 2021 [monthly]
Not Yet Recruiting PHASE4
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Flinders Medical Centre
- Mater Mothers' Hospital
- Royal North Shore Hospital
- South Australian Health and Medical Research Institute
- The Royal Women's Hospital
- Women's and Children's Hospital, Australia
For direct contact, visit the study record on ClinicalTrials.gov .